Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0000950170-25-038855

Director bought 6,000 shares at $10.21 ($61,250)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Wendy B. Director 2025-03-12 Purchase +6,000 $10.21 $61,250 6,000 D
Open-market purchases · 6,000 sh · avg $10.21 · $61,250
Loading xslF345X05/ownership.xml…